Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions highlight specific findings from the RAFT trial, such as mentioning the survival benefits of CRT-D over traditional ICDs after nearly 14 years of follow-up. Phrases like 'survival benefit' and 'long-term outcomes' used by users convey a sense of urgency and relevance, suggesting that the publication holds transformative potential for heart failure treatment.
Most discussions express a positive sentiment towards the findings of the study, indicating general support for the benefits of CRT-D.
There is a widespread curiosity about the outcomes of the study, with many expressing interest in how these findings could influence clinical practices.
While a few discussions delve deeply into methodological details, many posts primarily summarize the findings without extensive analysis.
Many participants perceive the study's outcomes as having significant implications for treatment strategies in heart failure.
Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B Editorial: Seeking More Time with Synchrony https://t.co/uvQ822uP8T #HeartFailure https://t.co/UlcAIcyEcX
Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a defibrillator as compared with those who received a defibrillator alone. Read the full RAFT trial results and Research Summary: https://t.co/BqpxTVC65B https://t.co/QZTtfrmppv
Long-Term Outcomes of Resynchronization–Defibrillation for #HF Follow-up at a median of nearly 14 yrs showed a survival benefit for pts who received CRT-D as compared with those who received a defibrillator alone. Read the full RAFT trial results: https://t.co/YjPhWzvzQp https://t.co/g34bBul3rV
Evidence for the longer-term survival benefit associated with receipt of a CRT-D compared with ICD (median ~14 years follow-up). https://t.co/Vebykggnws
#EPeeps Long-Term Outcomes of CRT_D for Heart Failure | NEJM https://t.co/ImcRbGCUED @SeddingUni @unimedhal @GerdHindricks @Phiso_de @RolandTilz @chris_sohns @Dr_Santangeli @MRazminia @Hapa_EP @shivkumarmd @ShaojieChen1 @DrBerruezo @Dr_Nazarian_EP @EP_Leiden @IngoEitel
From #RAFT_Long_term study @NEJM in 1050 pts with #HFrEF LVEF 30% or less + QRS>120 msec randomised to CRT-D or ICD [#NYHA II-III]: CRT-D gave survival benefit at median of almost 14 yrs #CardioTwitter @BSHeartFailure @SheffieldRhythm @ShefUni_ClinMed https://t.co/nJenZN8E2H
Join our scientific team as we discuss the most clinically impactful papers of the month, including findings on cardiac-resynchronization therapy and its long-term benefits over traditional defibrillators for heart…
This week, John Mandrola MD discusses the implications of left atrial appendage occlusion (LAAO) during cardiac surgery for stroke prevention in atrial fibrillation. Evidence indicates a significant reduction in stroke…
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | New England Journal of Medicine https://t.co/wWrC8rjJvj
RT @Dr_Habib_Khan: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | New England Journal of Medicine https://t.co/…
RT @Dr_Habib_Khan: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | New England Journal of Medicine https://t.co/…
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | New England Journal of Medicine https://t.co/bJW8TbfmjK @LHSCCanada @LHSFCanada @AnthonyTang6 @johnlsapp
Resultados a largo plazo de la resincronización y desfibrilación en la insuficiencia cardíaca | Revista de medicina de Nueva Inglaterra https://t.co/Idifds4dHk
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure #science #publication #research #publications https://t.co/8cY58MDliF
DATI A LUNGO TERMINE DALLO STUDIO RAFT: UNA CRT È PER SEMPRE! Fonte: Sapp, et al. 10.1056/NEJMoa2304542. #news a cura di: Francesco Gentile • LEGGI ORA: https://t.co/JjMn7cs6Vb ❤️ La #salute #cardiovascolare é nel nostro #cuore
RT @ctsnetorg: JANS: “Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure” from The New England Journal of Medicine |…
JANS: “Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure” from The New England Journal of Medicine | This follow-up study confirms the results of a previous five-year study.
RT @2minmed: #VisualAbstract: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure https://t.co/sKYaBuJAQC #StudyGraphi…
#VisualAbstract: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure https://t.co/sKYaBuJAQC #StudyGraphics #cardiacresynchronizationtherapy https://t.co/itDreJNjWO
Resultados a largo plazo de la resincronización y desfibrilación en la insuficiencia cardíaca | NEJM https://t.co/1ciNf3FkqT
RT @cardio_tu: 2 min cardiology（臨床論文、担当：千葉貴彦） Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure（RAFT long-term stud…
RT @ArashArya_EP: #EPeeps Long-Term Outcomes of CRT_D for Heart Failure | NEJM https://t.co/ImcRbGCUED @SeddingUni @unimedhal @GerdHindri…
2 min cardiology（臨床論文、担当：千葉貴彦） Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure（RAFT long-term study） John L Sapp et al. N Engl J Med 2024; 390: 212-20 https://t.co/z61YSkaUhZ ＃Cardiology ＃RAFT →
RT @ArashArya_EP: #EPeeps Long-Term Outcomes of CRT_D for Heart Failure | NEJM https://t.co/ImcRbGCUED @SeddingUni @unimedhal @GerdHindri…
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | NEJM https://t.co/2paCWNpay5
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @ArashArya_EP: #EPeeps Long-Term Outcomes of CRT_D for Heart Failure | NEJM https://t.co/ImcRbGCUED @SeddingUni @unimedhal @GerdHindri…
RT @ArashArya_EP: #EPeeps Long-Term Outcomes of CRT_D for Heart Failure | NEJM https://t.co/ImcRbGCUED @SeddingUni @unimedhal @GerdHindri…
#EPeeps Long-Term Outcomes of CRT_D for Heart Failure | NEJM https://t.co/ImcRbGCUED @SeddingUni @unimedhal @GerdHindricks @Phiso_de @RolandTilz @chris_sohns @Dr_Santangeli @MRazminia @Hapa_EP @shivkumarmd @ShaojieChen1 @DrBerruezo @Dr_Nazarian_EP @EP_Leiden @IngoEitel
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @kaulcsmc: https://t.co/sSxcqAD5OB "Although this trial included all patients at eight highest-enrolling sites (1050 out of 1798 from 34…
RT @kaulcsmc: https://t.co/sSxcqAD5OB "Although this trial included all patients at eight highest-enrolling sites (1050 out of 1798 from 34…
RT @kaulcsmc: https://t.co/sSxcqAD5OB "Although this trial included all patients at eight highest-enrolling sites (1050 out of 1798 from 34…
https://t.co/sSxcqAD5OB "Although this trial included all patients at eight highest-enrolling sites (1050 out of 1798 from 34 centers), this population is nonetheless a subset of entire trial population, so our observations should be interpreted cautiously." ARD=5.3% over 14y!!
Interesting outcome of RAFT comparing CRT-D to standard ICDs, but it makes sense when thinking how CRT can help stop/reverse cardiac remodeling and reduce new onset ventricular arrhythmias https://t.co/XCrxH0rjnc
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a defibrillator as compared with those who received a defibrillator alone. Read the full RAFT trial results and Research Summary: https://t.co/BqpxTVC65B https://t.co/QZTtfrmppv
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
Reiterating #clinicalquestion from @drjohnm : In the era of new and improved OMT.. would the "old" ICD and BiV ICD trials show the same benefit? https://t.co/SZk0nPMmqy @NEJM
https://t.co/rDrFiYV6CV
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @takekisuzuki: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | NEJM https://t.co/LUidccGcOk
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @takekisuzuki: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | NEJM https://t.co/LUidccGcOk
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/1wapaXJK8M Editorial: Seeking More Time with Synchrony https://t.co/1IXjnbC3rL https://t.co/KmSaevPof9
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | NEJM https://t.co/LUidccGcOk
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
RT @NEJM: Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B…
Original Article: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT trial) https://t.co/BqpxTVC65B Editorial: Seeking More Time with Synchrony https://t.co/uvQ822uP8T #HeartFailure https://t.co/UlcAIcyEcX
RT @JTLLERGO: ⚠️ Long-Term Outcomes of Resynchronization–Defibrillation for HF (RAFT trial)‼️
RT @NEJM: Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a def…
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | NEJM https://t.co/22GpmMFsEz
RT @cpgale3: Evidence for the longer-term survival benefit associated with receipt of a CRT-D compared with ICD (median ~14 years follow-up…
RT @cpgale3: Evidence for the longer-term survival benefit associated with receipt of a CRT-D compared with ICD (median ~14 years follow-up…
RT @JTLLERGO: ⚠️ Long-Term Outcomes of Resynchronization–Defibrillation for HF (RAFT trial)‼️
https://t.co/gcePGBosxp NYHA2度以上の心不全患者に対してCRT-DとICDで全因死亡に差があるかを調べたRCT 結果は、CRT-Dのほうが死亡率が少なかった(acceletion factor:0.80[0.66-0.90]、平均追跡期間7.7年) #当麻_循環
RT @JTLLERGO: ⚠️ Long-Term Outcomes of Resynchronization–Defibrillation for HF (RAFT trial)‼️
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | NEJM https://t.co/M0MW5E5AaX
RT @ZHeart11768530: Long-Term Outcomes of Resynchronization–Defibrillation for #HF Follow-up at a median of nearly 14 yrs showed a surviva…
RT @ZHeart11768530: Long-Term Outcomes of Resynchronization–Defibrillation for #HF Follow-up at a median of nearly 14 yrs showed a surviva…
RT @cpgale3: Evidence for the longer-term survival benefit associated with receipt of a CRT-D compared with ICD (median ~14 years follow-up…
RT @ZHeart11768530: Long-Term Outcomes of Resynchronization–Defibrillation for #HF Follow-up at a median of nearly 14 yrs showed a surviva…
RT @Susumu_Manabe: 心不全症状があって、駆出率が30％なくて、心電図QRS波形が広い人は、心室同期療法（ICD)は生命予後改善に有効。植え込み除細動器（ICD)と心室再同期療法の無作為化比較試験。 https://t.co/MWuZDXiY32
RT @JTLLERGO: ⚠️ Long-Term Outcomes of Resynchronization–Defibrillation for HF (RAFT trial)‼️
RT @cpgale3: Evidence for the longer-term survival benefit associated with receipt of a CRT-D compared with ICD (median ~14 years follow-up…
RT @cpgale3: Evidence for the longer-term survival benefit associated with receipt of a CRT-D compared with ICD (median ~14 years follow-up…
Evidence for the longer-term survival benefit associated with receipt of a CRT-D compared with ICD (median ~14 years follow-up). https://t.co/Vebykggnws
RT @echo_batman: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | NEJM https://t.co/mKdaMZLeMN
RT @ZHeart11768530: Long-Term Outcomes of Resynchronization–Defibrillation for #HF Follow-up at a median of nearly 14 yrs showed a surviva…
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure | NEJM https://t.co/mKdaMZLeMN
RT @ZHeart11768530: Long-Term Outcomes of Resynchronization–Defibrillation for #HF Follow-up at a median of nearly 14 yrs showed a surviva…
RT @JTLLERGO: ⚠️ Long-Term Outcomes of Resynchronization–Defibrillation for HF (RAFT trial)‼️
RT @JTLLERGO: ⚠️ Long-Term Outcomes of Resynchronization–Defibrillation for HF (RAFT trial)‼️
RT @ZHeart11768530: Long-Term Outcomes of Resynchronization–Defibrillation for #HF Follow-up at a median of nearly 14 yrs showed a surviva…
RT @ZHeart11768530: Long-Term Outcomes of Resynchronization–Defibrillation for #HF Follow-up at a median of nearly 14 yrs showed a surviva…
Long-Term Outcomes of Resynchronization–Defibrillation for #HF Follow-up at a median of nearly 14 yrs showed a survival benefit for pts who received CRT-D as compared with those who received a defibrillator alone. Read the full RAFT trial results: https://t.co/YjPhWzvzQp https://t.co/g34bBul3rV
RT @AAlMohammad87: From #RAFT_Long_term study @NEJM in 1050 pts with #HFrEF LVEF 30% or less + QRS>120 msec randomised to CRT-D or ICD [#NY…
RT @AAlMohammad87: From #RAFT_Long_term study @NEJM in 1050 pts with #HFrEF LVEF 30% or less + QRS>120 msec randomised to CRT-D or ICD [#NY…
RT @AAlMohammad87: From #RAFT_Long_term study @NEJM in 1050 pts with #HFrEF LVEF 30% or less + QRS>120 msec randomised to CRT-D or ICD [#NY…
RT @AAlMohammad87: From #RAFT_Long_term study @NEJM in 1050 pts with #HFrEF LVEF 30% or less + QRS>120 msec randomised to CRT-D or ICD [#NY…
From #RAFT_Long_term study @NEJM in 1050 pts with #HFrEF LVEF 30% or less + QRS>120 msec randomised to CRT-D or ICD [#NYHA II-III]: CRT-D gave survival benefit at median of almost 14 yrs #CardioTwitter @BSHeartFailure @SheffieldRhythm @ShefUni_ClinMed https://t.co/nJenZN8E2H